This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Anders Naar, Ph.D.
Founder at Elenae Therapeutics


Anders M. Naar is a Professor of Metabolic Biology in the Department of Nutritional Sciences & Toxicology at the University of California, Berkeley. He received a B.S. degree in biochemistry/biotechnology from the University of Lund, Sweden, in 1988, and a Ph.D. in Molecular Pathology with M. Geoff Rosenfeld at UC San Diego/HHMI in 1995, studying nuclear hormone receptor mechanisms of gene regulation. He was a postdoctoral research fellow with Robert Tjian at UC Berkeley/HHMI, where he discovered the human Mediator transcriptional co-activator complex. Dr. Näär was a Professor in the Department of Cell Biology, Harvard Medical School and the Massachusetts General Hospital Cancer Center, from 2001-2018.

Agenda Sessions

  • Therapeutic Targeting of a Pathological MicroRNA in Duchenne Muscular Dystrophy